Upstream Bio, Stock Buy Hold or Sell Recommendation
| UPB Stock | 19.19 0.26 1.34% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Upstream Bio, is 'Hold'. Macroaxis provides Upstream Bio, buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding UPB positions.
Check out Upstream Bio, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide. In addition, we conduct extensive research on individual companies such as Upstream and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Upstream Bio,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
Upstream |
Execute Upstream Bio, Buy or Sell Advice
The Upstream recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Upstream Bio,. Macroaxis does not own or have any residual interests in Upstream Bio, or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Upstream Bio,'s advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Modest | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Upstream Bio, Trading Alerts and Improvement Suggestions
| Upstream Bio, had very high historical volatility over the last 90 days | |
| Latest headline from gurufocus.com: Upstream Bio Appoints Allison Ambrose as General Counsel |
Upstream Bio, current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Upstream analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Upstream analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Average Consensus Strong Buy
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Upstream Bio, Returns Distribution Density
The distribution of Upstream Bio,'s historical returns is an attempt to chart the uncertainty of Upstream Bio,'s future price movements. The chart of the probability distribution of Upstream Bio, daily returns describes the distribution of returns around its average expected value. We use Upstream Bio, price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Upstream Bio, returns is essential to provide solid investment advice for Upstream Bio,.
| Mean Return | 0.45 | Value At Risk | -6.88 | Potential Upside | 10.61 | Standard Deviation | 6.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Upstream Bio, historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Upstream Bio, Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Upstream Bio, or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Upstream Bio,'s price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Upstream stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.43 | |
β | Beta against Dow Jones | 0.66 | |
σ | Overall volatility | 6.92 | |
Ir | Information ratio | 0.06 |
Upstream Bio, Volatility Alert
Upstream Bio, is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Upstream Bio,'s stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Upstream Bio,'s stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Upstream Bio, Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Upstream . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 10969.51 | |||
| Daily Balance Of Power | (0.19) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 19.49 | |||
| Day Typical Price | 19.39 | |||
| Price Action Indicator | (0.42) | |||
| Period Momentum Indicator | (0.26) |
About Upstream Bio, Buy or Sell Advice
When is the right time to buy or sell Upstream Bio,? Buying financial instruments such as Upstream Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Upstream Bio, in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Office Supplies Thematic Idea Now
Office Supplies
Companies producing and selling office supplies, and accessories. The Office Supplies theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Office Supplies Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Upstream Bio, Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Upstream Stock refer to our How to Trade Upstream Stock guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Upstream Bio,. If investors know Upstream will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Upstream Bio, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Upstream Bio, is measured differently than its book value, which is the value of Upstream that is recorded on the company's balance sheet. Investors also form their own opinion of Upstream Bio,'s value that differs from its market value or its book value, called intrinsic value, which is Upstream Bio,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Upstream Bio,'s market value can be influenced by many factors that don't directly affect Upstream Bio,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Upstream Bio,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Upstream Bio, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Upstream Bio,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.